India’s Sun Pharma Warns Taro Board Against Selling Irish Plant
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's Sun Pharmaceutical has warned the board of Israel's Taro Pharmaceutical to halt moves to sell a drug manufacturing unit in Ireland as the two firms dispute whether a year-old merger agreement remains in effect